ZAGAZIG UNIVERSITY
🇪🇬Egypt
- Country
- 🇪🇬Egypt
- Ownership
- Private
- Established
- 1974-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://english.zu.edu.eg
Biliary Fistula and Late Recurrence of Liver Hydatid Cyst: Role of Cysto-biliary Communication
Not Applicable
Completed
- Conditions
- Liver Surgery
- Interventions
- Procedure: laparoscopic partial cystectomy with omentoplasty
- First Posted Date
- 2021-11-11
- Last Posted Date
- 2023-06-28
- Lead Sponsor
- Zagazig University
- Target Recruit Count
- 244
- Registration Number
- NCT05116735
Methylene Blue Spray for Identification of Recurrent Laryngeal Nerve and Parathyroid Gland
Not Applicable
Completed
- Conditions
- Methylene BlueParathyroid GlandRecurrent Laryngeal Nerve Injuries
- Interventions
- Diagnostic Test: methylene blue identification
- First Posted Date
- 2021-11-09
- Last Posted Date
- 2021-11-09
- Lead Sponsor
- Zagazig University
- Target Recruit Count
- 80
- Registration Number
- NCT05113628
- Locations
- 🇪🇬
Zagazig university hospitals, Zagazig, Egypt
Interleukin 4 and Interferon Gamma Predictors of Human Papillomavirus Immunotherapy in Warts
Completed
- Conditions
- Wart, GenitalWarts Hand
- Interventions
- Biological: IL-4 and IFN-γ measurements
- First Posted Date
- 2021-10-29
- Last Posted Date
- 2025-02-19
- Lead Sponsor
- Zagazig University
- Target Recruit Count
- 80
- Registration Number
- NCT05100043
- Locations
- 🇪🇬
Zagazig University Faculty of Medicine, Zagazig, Sharkia, Egypt
Is Fetal Hemoglobin a Key for Improvement of Hypoxia and Saving Last Breath in COVID-19 Patient?. A Pilot Study.
Not Applicable
- Conditions
- COVID-19 Acute Respiratory Distress Syndrome
- Interventions
- Procedure: fetal blood transfusion
- First Posted Date
- 2021-10-25
- Last Posted Date
- 2021-11-23
- Lead Sponsor
- Zagazig University
- Target Recruit Count
- 20
- Registration Number
- NCT05092724
A New Scoring Model to Diagnose COVID-19 Using Lung Ultrasound in the Emergency Department
Completed
- Conditions
- COVID-19 Pneumonia
- Interventions
- Device: ultra sound
- First Posted Date
- 2021-10-14
- Last Posted Date
- 2021-10-14
- Lead Sponsor
- Zagazig University
- Target Recruit Count
- 82
- Registration Number
- NCT05077202
- Locations
- 🇪🇬
zagazigU, Zagazig, Egypt
Combined Endoscopic & Radiologic Intervention For Management Of Acute Perforated Peptic Ulcer
Not Applicable
Completed
- Conditions
- Abdomen, Acute
- Interventions
- Procedure: combined endoscopic & radiologic intervention for management of acute perforated peptic ulcer
- First Posted Date
- 2021-09-21
- Last Posted Date
- 2021-09-21
- Lead Sponsor
- Zagazig University
- Target Recruit Count
- 100
- Registration Number
- NCT05051683
- Locations
- 🇪🇬
Zagazig University Hospitals, Zagazig, Sharqua, Egypt
Recurrent Appendicitis Following Successful Drainage of Appendicular Abscess in Adult
Completed
- Conditions
- Appendicitis
- First Posted Date
- 2021-09-17
- Last Posted Date
- 2021-09-23
- Lead Sponsor
- Zagazig University
- Target Recruit Count
- 316
- Registration Number
- NCT05048745
- Locations
- 🇪🇬
Tamer Alsaied Alnaimy, Zagazig, Sharkia, Egypt
Epidural Nalbuphine Versus Dexmedetomidine as Adjuvants to Bupivacaine in Lower Limb Surgeries
Not Applicable
Completed
- Conditions
- Lower Limb Surgeries
- Interventions
- First Posted Date
- 2021-09-13
- Last Posted Date
- 2023-05-12
- Lead Sponsor
- Zagazig University
- Target Recruit Count
- 23
- Registration Number
- NCT05041270
- Locations
- 🇪🇬
faculty of medicine, Zagazig university, Zagazig, Elsharqya, Egypt
Suprascapular Nerve Block With Oral Gabapentin For Pain Management In Frozen Shoulder
Not Applicable
Completed
- Conditions
- Pain, Shoulder
- Interventions
- Procedure: Ultrasound Guided Continuous Suprascapular Nerve Block With methyl prednisolone and marcaine
- First Posted Date
- 2021-09-08
- Last Posted Date
- 2021-11-16
- Lead Sponsor
- Zagazig University
- Target Recruit Count
- 40
- Registration Number
- NCT05037994
- Locations
- 🇪🇬
Amr Shaaban Elshafei, Zagazig, Egypt
Ranibizumab Vs Bevacizumab for Type 1 Retinopathy of Prematurity
Phase 3
- Conditions
- Retinopathy of Prematurity Both Eyes
- Interventions
- Drug: Bevacizumab, Ranibizumab
- First Posted Date
- 2021-09-02
- Last Posted Date
- 2021-09-02
- Lead Sponsor
- Zagazig University
- Target Recruit Count
- 36
- Registration Number
- NCT05033106
- Locations
- 🇪🇬
Zagazig University, Zagazig, Egypt
© Copyright 2025. All Rights Reserved by MedPath